Hepatic fibrosis

Common Name(s)

Hepatic fibrosis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatic fibrosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatic fibrosis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hepatic fibrosis" returned 349 free, full-text research articles on human participants. First 3 results:

Laparoscopic distal splenoadrenal shunt for the treatment of portal hypertension in children with congenital hepatic fibrosis: A case report.
 

Author(s): Jin-Shan Zhang, Wei Cheng, Long Li

Journal: Medicine (Baltimore). 2017 Jan;96(3):e5843.

 

The distal splenorenal shunt is an effective procedure for the treatment of portal hypertension in children. However, there has been no report about laparoscopic distal splenorenal shunt in the treatment of portal hypertension in children.

Last Updated: 18 Jan 2017

Go To URL
Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study.
 

Author(s): Seema N Desai, Jennifer L Dodge, Alan L Landay, Marshall J Glesby, Patricia S Latham, Maria C Villacres, Audrey L French, Stephen J Gange, Ruth M Greenblatt, Marion G Peters

Journal: Medicine (Baltimore). 2016 Aug;95(33):e4483.

 

HCV and HIV independently lead to immune dysregulation. The mechanisms leading to advanced liver disease progression in HCV/HIV coinfected subjects remain unclear.In this cross-sectional study, we assessed the association of HCV viremia, liver fibrosis, and immune response patterns ...

Last Updated: 19 Aug 2016

Go To URL
Congenital hepatic fibrosis: clinical presentation, laboratory features and management at a tertiary care hospital of Lahore.
 

Author(s): Arit Parkash, Huma Arshad Cheema, Hassan Suleman Malik, Zafar Fayyaz

Journal: J Pak Med Assoc. 2016 Aug;66(8):984-8.

 

To describe the clinical presentations, laboratory features and management of congenital hepatic fibrosis patients at a tertiary care hospital.

Last Updated: 15 Aug 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hepatic fibrosis" returned 56 free, full-text review articles on human participants. First 3 results:

Evidence for a "Pathogenic Triumvirate" in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease.
 

Author(s): Lu Jiang, Pingping Fang, James L Weemhoff, Udayan Apte, Michele T Pritchard

Journal: Biomed Res Int. 2016 ;2016():4918798.

 

Autosomal recessive polycystic kidney disease (ARPKD) is a severe monogenic disorder that occurs due to mutations in the PKHD1 gene. Congenital hepatic fibrosis (CHF) associated with ARPKD is characterized by the presence of hepatic cysts derived from dilated bile ducts and a robust, ...

Last Updated: 28 Nov 2016

Go To URL
[Inflammation and Hepatic Fibrosis, Then Hepatocellular Carcinoma].
 

Author(s): Oh Sang Kwon, Seong Han Choi, Ju Hyun Kim

Journal: Korean J Gastroenterol. 2015 Dec;66(6):320-4.

 

Inflammation is one of the most prominent characteristic features of chronic liver disease, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Most of HCC cases develop in patients with cirrhosis and cirrhosis develops in patients with chronic liver inflammation. Therefore, ...

Last Updated: 22 Dec 2015

Go To URL
New therapies for hepatic fibrosis.
 

Author(s): Yukinori Koyama, David A Brenner

Journal: Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1():S75-9.

 

Liver fibrosis is an outcome of many chronic diseases, and often results in cirrhosis, liver failure, and portal hypertension. Liver transplantation is the only treatment available for patients with advanced stages of liver cirrhosis. Therefore, alternative methods are required to ...

Last Updated: 2 Oct 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

S-Shearwave Elastography for Assessment of Hepatic Fibrosis
 

Status: Not yet recruiting

Condition Summary: Liver Fibroses

 

Last Updated: 8 Feb 2017

Go to URL
Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
 

Status: Recruiting

Condition Summary: Chronic Hepatitis B; Hepatic Fibrosis; Fatty Liver

 

Last Updated: 13 Oct 2016

Go to URL
Optimized Treatment and Regression of HBV-induced Liver Fibrosis
 

Status: Recruiting

Condition Summary: Liver Fibrosis

 

Last Updated: 12 Jan 2016

Go to URL